These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30389671)

  • 1. Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010-2015.
    Rigobon AV; Kalia S; Nichols J; Aliarzadeh B; Greiver M; Moineddin R; Sullivan F; Yu C
    Diabetes Care; 2019 Jan; 42(1):148-156. PubMed ID: 30389671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study.
    Greiver M; Kalia S; Moineddin R; Chen S; Duchen R; Rigobon A
    BMC Health Serv Res; 2020 May; 20(1):370. PubMed ID: 32357891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
    Tjia J; Briesacher BA
    J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
    Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a smartphone-based intervention on secondary prevention medication prescriptions after coronary artery bypass graft surgery: The MISSION-1 randomized controlled trial.
    Qu J; Du J; Rao C; Chen S; Gu D; Li J; Zhang H; Zhao Y; Hu S; Zheng Z;
    Am Heart J; 2021 Jul; 237():79-89. PubMed ID: 33689732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
    LaMarr B; Valdez C; Driscoll K; Ryan M
    Am J Health Syst Pharm; 2010 Feb; 67(4):290-4. PubMed ID: 20133534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.
    Guénette L; Breton MC; Hamdi H; Grégoire JP; Moisan J
    Can J Cardiol; 2013 Dec; 29(12):1593-8. PubMed ID: 24183301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
    Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
    Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 12. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.
    Ohlsson H; Merlo J
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):682-90. PubMed ID: 19437457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
    Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
    J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discharge prescription patterns for antiplatelet and statin therapy following carotid endarterectomy: an analysis of the vascular quality initiative.
    Eppler M; Singh N; Ding L; Magee G; Garg P
    BMJ Open; 2023 Jul; 13(7):e071550. PubMed ID: 37491096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study.
    Ortolani P; Di Bartolomeo S; Marino M; Vagnarelli F; Guastaroba P; Rapezzi C; De Palma R
    Eur Heart J Cardiovasc Pharmacother; 2015 Oct; 1(4):254-9. PubMed ID: 27532449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease.
    Steenhof N; Le Piane F; Leblanc K; Eisenberg NR; Kwan Y; Malmberg C; Papadopoulos A; Roche-Nagle G
    Vasc Health Risk Manag; 2014; 10():333-40. PubMed ID: 24940068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
    Tiwari A; Tseng CL; Kern EF; Maney M; Miller DR; Pogach L
    Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the JUPITER trial on statin prescribing for primary prevention.
    Teng JF; Gomes T; Camacho X; Grundy S; Juurlink DN; Mamdani MM
    Pharmacotherapy; 2014 Jan; 34(1):9-18. PubMed ID: 23940007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Clinical Practice Guidelines on Blood Glucose Test Strip Prescription Rates in Manitoba and Saskatchewan (Canada): An Interrupted Time-Series Analysis.
    Nichols J; Mamdani M; Gomes T; Shah BR; Casey CG; Yu CH
    Can J Diabetes; 2021 Aug; 45(6):557-565.e2. PubMed ID: 33558147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.